FDA Inspection
Inova Schar Cancer InstituteInova Schar Cancer Institute – FDA Inspection, Sep 26, 2017
Record Details
This FDA Inspection record concerns Inova Schar Cancer Institute, with an inspection on September 26, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · dffa3539-7927-481d-a0fc-3a00a83b4962
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026568
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Inova Schar Cancer Institute
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 9, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 31, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 15, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 16, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 25, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Inova Schar Cancer Institute
- FDA Inspection 1266988 - 2025-04-09
- FDA Inspection 1167056 - 2022-03-31
- FDA Inspection 1117080 - 2020-01-15
- FDA Inspection 930127 - 2015-06-16
- FDA Inspection 849408 - 2013-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.